芹菜素对产前丙戊酸诱导的自闭症谱系障碍大鼠的神经保护作用。

IF 2 Q3 NEUROSCIENCES

IBRO Neuroscience Reports Pub Date : 2024-12-01 DOI:10.1016/j.ibneur.2024.10.003

Mitra Farbin , Anahita Hejazi , Nahid Fakhraei , Yaser Azizi , Soraya Mehrabi , Razieh Hajisoltani

{"title":"芹菜素对产前丙戊酸诱导的自闭症谱系障碍大鼠的神经保护作用。","authors":"Mitra Farbin , Anahita Hejazi , Nahid Fakhraei , Yaser Azizi , Soraya Mehrabi , Razieh Hajisoltani","doi":"10.1016/j.ibneur.2024.10.003","DOIUrl":null,"url":null,"abstract":"<div><div>Valproic acid (VPA) demonstrates teratogenic effects during pregnancy. Prenatal exposure to VPA may result in autism spectrum disorder (ASD) -like phenotypes. Apigenin, a natural flavonoid, has been shown to have neuroprotective impacts due to its antioxidant properties. This study aimed to investigate the protective effects of apigenin in prenatal Valproic acid-induced autism in rats. Female rats (220–240 g, 2–3 months) received a single dose of VPA (600 mg/kg, i.p.) on the 12.5th day of gestational. The male offspring were given oral apigenin (50 mg/kg, p.o.) or the vehicle for 30 days. Behavioral tests, biochemical assessments for oxidative stress markers and pro-inflammatory cytokines were performed. VPA-treated rats exhibited increased anxiety-like behavior, and repetitive behavior. Social interaction was reduced, and detection of the novel object was impaired. Also, VPA-treated rats have shown higher levels of oxidative stress malondialdehyde (MDA) and lower GPX and superoxide dismutase (SOD) levels. Furthermore, IL-6 and TNF-α increased in the prefrotalcortex decreased. On the other hand, apigenin-treated rats restored the cognitive consequences and lowered oxidative stress and inflammation in the prefrotalcortex.</div></div><div><h3>Conclusion</h3><div>Chronic apigenin treatment restored the behavioral and biochemical abnormalities caused by prenatal VPA exposure.</div></div>","PeriodicalId":13195,"journal":{"name":"IBRO Neuroscience Reports","volume":"17 ","pages":"Pages 493-502"},"PeriodicalIF":2.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11667072/pdf/","citationCount":"0","resultStr":"{\"title\":\"Neuroprotective effects of Apigenin on prenatal Valproic acid-induced autism spectrum disorder in rats\",\"authors\":\"Mitra Farbin , Anahita Hejazi , Nahid Fakhraei , Yaser Azizi , Soraya Mehrabi , Razieh Hajisoltani\",\"doi\":\"10.1016/j.ibneur.2024.10.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Valproic acid (VPA) demonstrates teratogenic effects during pregnancy. Prenatal exposure to VPA may result in autism spectrum disorder (ASD) -like phenotypes. Apigenin, a natural flavonoid, has been shown to have neuroprotective impacts due to its antioxidant properties. This study aimed to investigate the protective effects of apigenin in prenatal Valproic acid-induced autism in rats. Female rats (220–240 g, 2–3 months) received a single dose of VPA (600 mg/kg, i.p.) on the 12.5th day of gestational. The male offspring were given oral apigenin (50 mg/kg, p.o.) or the vehicle for 30 days. Behavioral tests, biochemical assessments for oxidative stress markers and pro-inflammatory cytokines were performed. VPA-treated rats exhibited increased anxiety-like behavior, and repetitive behavior. Social interaction was reduced, and detection of the novel object was impaired. Also, VPA-treated rats have shown higher levels of oxidative stress malondialdehyde (MDA) and lower GPX and superoxide dismutase (SOD) levels. Furthermore, IL-6 and TNF-α increased in the prefrotalcortex decreased. On the other hand, apigenin-treated rats restored the cognitive consequences and lowered oxidative stress and inflammation in the prefrotalcortex.</div></div><div><h3>Conclusion</h3><div>Chronic apigenin treatment restored the behavioral and biochemical abnormalities caused by prenatal VPA exposure.</div></div>\",\"PeriodicalId\":13195,\"journal\":{\"name\":\"IBRO Neuroscience Reports\",\"volume\":\"17 \",\"pages\":\"Pages 493-502\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11667072/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IBRO Neuroscience Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667242124000897\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IBRO Neuroscience Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667242124000897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 0

摘要

丙戊酸（VPA）在怀孕期间有致畸作用。产前暴露于VPA可能导致自闭症谱系障碍（ASD）样表型。芹菜素是一种天然类黄酮，由于其抗氧化特性，已被证明具有神经保护作用。本研究旨在探讨芹菜素对产前丙戊酸致自闭症大鼠的保护作用。雌性大鼠（220-240 g， 2-3月龄）在妊娠第12.5天给予单剂量VPA（600 mg/kg, i.p.）。雄性子代口服芹菜素（50 mg/kg, p.o.）或载药30 d。进行行为测试、氧化应激标志物和促炎细胞因子的生化评估。vpa处理的大鼠表现出增加的焦虑样行为和重复行为。社会互动减少，对新事物的识别能力受损。此外，vpa处理的大鼠显示出更高水平的氧化应激丙二醛（MDA）和更低的GPX和超氧化物歧化酶（SOD）水平。额前皮质IL-6、TNF-α升高，TNF-α降低。另一方面，芹菜素治疗的大鼠恢复了认知功能，降低了前额皮质的氧化应激和炎症。结论：慢性芹菜素治疗可恢复产前VPA暴露所致的行为和生化异常。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Neuroprotective effects of Apigenin on prenatal Valproic acid-induced autism spectrum disorder in rats

Valproic acid (VPA) demonstrates teratogenic effects during pregnancy. Prenatal exposure to VPA may result in autism spectrum disorder (ASD) -like phenotypes. Apigenin, a natural flavonoid, has been shown to have neuroprotective impacts due to its antioxidant properties. This study aimed to investigate the protective effects of apigenin in prenatal Valproic acid-induced autism in rats. Female rats (220–240 g, 2–3 months) received a single dose of VPA (600 mg/kg, i.p.) on the 12.5th day of gestational. The male offspring were given oral apigenin (50 mg/kg, p.o.) or the vehicle for 30 days. Behavioral tests, biochemical assessments for oxidative stress markers and pro-inflammatory cytokines were performed. VPA-treated rats exhibited increased anxiety-like behavior, and repetitive behavior. Social interaction was reduced, and detection of the novel object was impaired. Also, VPA-treated rats have shown higher levels of oxidative stress malondialdehyde (MDA) and lower GPX and superoxide dismutase (SOD) levels. Furthermore, IL-6 and TNF-α increased in the prefrotalcortex decreased. On the other hand, apigenin-treated rats restored the cognitive consequences and lowered oxidative stress and inflammation in the prefrotalcortex.